206 related articles for article (PubMed ID: 7478511)
1. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells.
Tamura T; Aoyama N; Saya H; Haga H; Futami S; Miyamoto M; Koh T; Ariyasu T; Tachi M; Kasuga M
Oncogene; 1995 Nov; 11(10):1939-46. PubMed ID: 7478511
[TBL] [Abstract][Full Text] [Related]
2. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
3. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
Sun SY; Yue P; Hong WK; Lotan R
Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways.
Sheikh MS; Li XS; Chen JC; Shao ZM; Ordonez JV; Fontana JA
Oncogene; 1994 Dec; 9(12):3407-15. PubMed ID: 7970699
[TBL] [Abstract][Full Text] [Related]
5. Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent.
Chen T; Turner J; McCarthy S; Scaltriti M; Bettuzzi S; Yeatman TJ
Cancer Res; 2004 Oct; 64(20):7412-9. PubMed ID: 15492264
[TBL] [Abstract][Full Text] [Related]
6. p53 promotes selection for Fas-mediated apoptotic resistance.
Maecker HL; Koumenis C; Giaccia AJ
Cancer Res; 2000 Aug; 60(16):4638-44. PubMed ID: 10969818
[TBL] [Abstract][Full Text] [Related]
7. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
8. Different p53 mutations produce distinct effects on the ability of colon carcinoma cells to become blocked at the G1/S boundary after irradiation.
Pocard M; Chevillard S; Villaudy J; Poupon MF; Dutrillaux B; Remvikos Y
Oncogene; 1996 Feb; 12(4):875-82. PubMed ID: 8632910
[TBL] [Abstract][Full Text] [Related]
9. Wild-type p53 demonstrates functional dominance in a human colon carcinoma cell line in which it induces reversible growth arrest.
Yang B; Stambrook PJ; Markowitz SD
Clin Cancer Res; 1996 Oct; 2(10):1639-47. PubMed ID: 9816111
[TBL] [Abstract][Full Text] [Related]
10. Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells.
Ho YS; Wang YJ; Lin JK
Mol Carcinog; 1996 May; 16(1):20-31. PubMed ID: 8634091
[TBL] [Abstract][Full Text] [Related]
11. p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells.
Kagawa S; Fujiwara T; Hizuta A; Yasuda T; Zhang WW; Roth JA; Tanaka N
Oncogene; 1997 Oct; 15(16):1903-9. PubMed ID: 9365236
[TBL] [Abstract][Full Text] [Related]
12. TNF-alpha induced p21(WAF1) but not Bax in colon cancer cells WiDr with mutated p53: important role of protein stabilization.
Kobayashi N; Takada Y; Hachiya M; Ando K; Nakajima N; Akashi M
Cytokine; 2000 Dec; 12(12):1745-54. PubMed ID: 11097743
[TBL] [Abstract][Full Text] [Related]
13. Acute and delayed apoptosis induced by thymidine deprivation correlates with expression of p53 and p53-regulated genes in colon carcinoma cells.
Harwood FG; Frazier MW; Krajewski S; Reed JC; Houghton JA
Oncogene; 1996 May; 12(10):2057-67. PubMed ID: 8668331
[TBL] [Abstract][Full Text] [Related]
14. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line.
Saied IT; Shamsuddin AM
Anticancer Res; 1998; 18(3A):1479-84. PubMed ID: 9673359
[TBL] [Abstract][Full Text] [Related]
16. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.
Cerrato JA; Khan T; Koul D; Lang FF; Conrad CA; Yung WK; Liu TJ
Int J Oncol; 2004 Feb; 24(2):409-17. PubMed ID: 14719118
[TBL] [Abstract][Full Text] [Related]
17. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
Kralj M; Husnjak K; Körbler T; Pavelić J
Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
[TBL] [Abstract][Full Text] [Related]
18. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.
Xu D; Wang Q; Gruber A; Björkholm M; Chen Z; Zaid A; Selivanova G; Peterson C; Wiman KG; Pisa P
Oncogene; 2000 Oct; 19(45):5123-33. PubMed ID: 11064449
[TBL] [Abstract][Full Text] [Related]
20. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells.
Sun SY; Yue P; Wu GS; El-Deiry WS; Shroot B; Hong WK; Lotan R
Cancer Res; 1999 Jun; 59(12):2829-33. PubMed ID: 10383141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
